Stock 603538 NINGBO MENOVO PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Ningbo Menovo Pharmaceutical Co., Ltd.

Equities

603538

CNE100002Y25

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
13.8 CNY +3.84% Intraday chart for Ningbo Menovo Pharmaceutical Co., Ltd. +8.58% -27.82%
04-29 Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-29 Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Ningbo Menovo Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of special active pharmaceutical ingredients (APIs) and medical intermediates. The Company’s products contain gastropathic medicine and cardiovascular medicine, which include anti-hypertension medicine, anti-hyperlipidemia medicine and anti-thrombus medicine. The Company distributes its products to both domestic and overseas markets.

Number of employees: 2,297

Sales per Business

CNY in Million2021Weight2022Weight Delta
Raw materials
46.7 %
748 59.4 % 681 46.7 % -8.92%
CDMO
34.6 %
265 21.1 % 504 34.6 % +89.99%
Preparation
15.3 %
153 12.1 % 223 15.3 % +45.89%
Medicine Circulation
2.2 %
79 6.3 % 32 2.2 % -59.59%
Other Business
1.2 %
13 1.1 % 17 1.2 % +29.00%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
63.4 %
636 51.1 % 913 63.4 % +43.48%
Abroad
36.6 %
609 48.9 % 527 36.6 % -13.42%

Managers

Managers TitleAgeSince
Cheng Zhi Yao CEO
 Chief Executive Officer 49 18/02/04
Gao Feng Ying DFI
 Director of Finance/CFO 53 11/10/19
Xiao Qing Zhang IRC
 Investor Relations Contact - -
Zhi Yan Fan PRN
 Corporate Officer/Principal 41 -

Members of the board

Members of the board TitleAgeSince
Cheng Zhi Yao CEO
 Chief Executive Officer 49 18/02/04
Zhi Yan Fan PRN
 Corporate Officer/Principal 41 -
Qian Cao BRD
 Director/Board Member 42 19/06/18
Hui Lin Li BRD
 Director/Board Member 67 19/06/18
Zi Min Ye BRD
 Director/Board Member 53 19/06/18
Fang Yao BRD
 Director/Board Member 35 11/05/21
Gao Feng Ying DFI
 Director of Finance/CFO 53 11/10/19
Lin Na Shu BRD
 Director/Board Member 36 26/01/22
Si Bin Liu CHM
 Chairman 53 06/12/21
Yi Ting Xu BRD
 Director/Board Member 29 18/11/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 216,063,749 147,745,170 ( 68.38 %) 2,712,260 ( 1.255 %) 68.38 %

Shareholders

NameEquities%Valuation
Rongtong Fund Management Co., Ltd.
1.610 %
3,400,000 1.610 % 7 M ¥
China Merchants Fund Management Co., Ltd.
0.0946 %
199,800 0.0946 % 387 578 ¥
Qian Cao
0.0910 %
192,103 0.0910 % 372 647 ¥
UBS SDIC Fund Management Co., Ltd.
0.0658 %
139,003 0.0658 % 269 642 ¥
Jian Xu
0.0465 %
98,262 0.0465 % 190 612 ¥
Everbright PGIM Fund Management Co. Ltd.
0.0372 %
78,600 0.0372 % 152 471 ¥
JPMorgan Asset Management (China) Co Ltd.
0.007543 %
15,927 0.007543 % 30 896 ¥
JT Asset Management Co., Ltd.
0.005491 %
11,595 0.005491 % 22 492 ¥
BSCOM Cathay Asset Management Co. Ltd.
0.003970 %
8,382 0.003970 % 16 260 ¥
Dongxing Asset Management Co. Ltd.
0.000426 %
900 0.000426 % 1 746 ¥
NameEquities%Valuation
Qian Cao
3.113 %
69,851 3.113 % 135 499 ¥

Company contact information

Ningbo Menovo Pharmaceutical Co., Ltd.

Room 1406 No. 1, Lane 999, Yangfan Road

315048, Ningbo

+

http://www.menovopharm.com
address Ningbo Menovo Pharmaceutical Co., Ltd.(603538)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Ningbo Menovo Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
13.8
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
NINGBO MENOVO PHARMACEUTICAL CO., LTD. Stock Ningbo Menovo Pharmaceutical Co., Ltd.
-27.82% 407M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 681B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 325B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 235B
NOVARTIS AG Stock Novartis AG
+3.65% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 189B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603538 Stock
  4. Company Ningbo Menovo Pharmaceutical Co., Ltd.